Epigral Ltd Q3 FY2024 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/1gf5n9pr18109mo7jbscdc5e.pdf

Key Takeaways


Demand & Pricing Environment

Maulik Patel: "We feel that that was extended one more quarter up to Q3 and probably from Q4 we are seeing some positive sign in terms of the recovery of the demand on started moving the inventory at least."

Volume Growth & Capacity Ramp-Up


Chlorotoluene: The Next Bet

Maulik Patel: "So, we believe that this market is going to increase in next 5 to 10 years' time and completely as a Make in India, people don't need to depend on other part or the third part of the world, and all the multinationals who are in the agro or pharma they also believe and they also need a complete value chain from, and as a second option other than the China country people need completely value, entire supply chain from India."

Epichlorohydrin Dynamics

Maulik Patel: "First of all, the CPVC is not like a PVC kind of technology which is available openly for setting up the plant. This is one first requirement."

Margins & Financials

Milind Kotecha: "Considering the current debt that we have all put together is around INR 940 crore, working capital and the long-term debt. So, that is a peak debt that we have, that debt will, down the line might reduce from here on."

Strategy & Long-Term Outlook

Kaushal Soparkar: "Good evening. I would like to convey that long-term story of India remains intact and current situation is short-term and looking at the Indian consumer story we are positive about long-term outlook, and we are working towards that through our future expansion and diversification in terms of multi-product catering various industries, we are targeting consistent growth both at top line and bottom line."

Guidance & Commitments

CommitmentSpecificsTimeline
CPVC Resin new capacity ramp-upOptimum utilization levelBy end of H1 FY25
CPVC compound utilization~50% of 35,000-ton capacityBy end of H1 FY25
Chlorotoluene capacity utilizationMore than 60% of capacity including derivativesBy end of FY25
Chlorotoluene import substitution15,000 tons capacity targeting 10 products currently importedBy FY2026
In-house chlorine consumptionReach ~85%In 2-3 years
Medium-term revenue targetPlus or minus 10-15% from previously guided numberIn next 3 years
Annual sustaining CapEx~₹300-350 crore per yearOngoing
Project completion (two near-complete)85% and 90% complete projects finishedBy end of Q4 FY24

Key Metrics

MetricQ3 FY24
Revenue₹472 cr, flat QoQ, down 14% YoY
EBITDA₹123 cr, up 14% QoQ
EBITDA margin26%, up from 23% in Q2 FY24
PAT₹49 cr, up 29% QoQ
PAT margin10%, up from 8% in Q2 FY24
Volume growth18% YoY in Q3 FY24, 17% for nine months FY24
Derivative & specialty revenue share42% in nine months FY24, up from 27% in nine months FY23
Overall capacity utilization81%, up from 77% in Q2 FY24
Net debt₹944 cr as on 31 Dec 2023, up ₹81 cr from 31 Mar 2023
Net debt to EBITDA1.96x, up from 1.83x in Q2 FY24
Net debt to equity0.8x, down from 0.85x in Q2 FY24
Return on capital employed (trailing 12M)18% including CWIP, 21% excluding CWIP
Epichlorohydrin capacity utilization55%–60%, up from 40%–45% in Q2 FY24
CPVC Resin capacity utilization~85%
Chlor-Alkali capacity utilization78%–80%, up from ~75% in Q2 FY24
ECU realization₹27,000–₹28,000
Caustic soda realization₹31,000–₹32,000
Epichlorohydrin realization₹1,00,000–₹1,05,000
Epichlorohydrin export share30%–35%
In-house chlorine consumption65%–70%, expected to reach ~85% in 2–3 years
CPVC Resin realization~₹140 (per kg)
Hydrogen Peroxide realization~₹25,000–₹26,000
Chloromethane realization~₹30,000–₹32,000
Cash outflow for capital expenditure (9M FY24)₹323 cr, with ~₹250 cr funded from internal accruals
Long-term debt~₹640 cr out of ₹944 cr total debt
Annual debt repayment schedule~₹180 cr
Redeemable preference shares outstanding₹120 cr as on 31 Dec 2023, down from peak of ₹211 cr
Annual continuous CapEx range₹300–₹350 cr
India CPVC Resin volume expectation by 2030~5 lakh tons